LONG [eLong,] 6-K: (Original Filing)

[On December 20, 2012 (Beijing time), eLong, (NASDAQ: LONG), a leading online travelmpany in China, held its annual general meeting of shareholders. At the meeting the following eleven persons were re-elected to the Board of Directors of eLong,: Fernando Gil de Bernab, Guangfu, Cui, Dhiren Fonseca, Thomas Gurnee,]

By | 2016-02-06T23:53:45+00:00 December 20th, 2012|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

LONG [eLong,] 6-K: On December 20, 2012 (Beijing time), eLong, (NASDAQ:

[On December 20, 2012 (Beijing time), eLong, (NASDAQ: LONG), a leading online travelmpany in China, held its annual general meeting of shareholders. At the meeting the following eleven persons were re-elected to the Board of Directors of eLong,: Fernando Gil de Bernab, Guangfu, Cui, Dhiren Fonseca, Thomas Gurnee,]

By | 2016-02-06T23:55:29+00:00 December 20th, 2012|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Results of 2012 Annual General Meeting HONG KONG, China, December 20, 2012 - China Cord Blood Corporation At the Annual General Meeting, shareholders · Ratified the appointment of KPMG as the independent auditor of the Company for the financial year ending March 31, 2013, and authorized any duly formed committee of the directors to fix]

By | 2016-02-29T14:00:09+00:00 December 20th, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Results of 2012

[China Cord Blood Corporation Announces Results of 2012 Annual General Meeting HONG KONG, China, December 20, 2012 - China Cord Blood Corporation At the Annual General Meeting, shareholders · Ratified the appointment of KPMG as the independent auditor of the Company for the financial year ending March 31, 2013, and authorized any duly formed committee of the directors to fix]

By | 2016-02-29T14:02:07+00:00 December 20th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

ZX [China Zenix Auto International] SC 13D: Joint Filing Agreement Jianhui Lai Newrace Limited EX-99.1

[Joint Filing Agreement Jianhui Lai Newrace Limited EX-99.1 2 d445873dex991.htm JOINT FILING AGREEMENT] [Notice of Exercise December 19 Dated: To: Lai Fan Chu Notice of Option Exercise Re: Dear Ms. Chu: Agreement Purchaser Seller Parties Party Reference is made to that certain Shares Purchase Option Agreement (the “ December 20 Completion Date 27,934,000.00 90 The Parties hereby agree that the 50,000 Option Shares shall be transferred and delivered to the Purchaser on This]

By | 2016-02-29T20:52:25+00:00 December 20th, 2012|Categories: Chinese Stocks, Webplus ver, ZX|Tags: , , , , , |0 Comments

ZX [China Zenix Auto International] 6-K: (Original Filing)

[ZENIX AUTO’S CHAIRMAN EXERCISES OPTION TO PURCHASE SHARES ZHANGZHOU, China, December 20, 2012 – China Zenix Auto International Limited (NYSE: ZX) Mr. Lai commented, “This transaction further aligns my interest with our other shareholders as we strengthen our strategies to capture market share in this challenging business environment, produce strong free cash-flow and prepare for the introduction of our new]

By | 2016-02-29T20:53:44+00:00 December 20th, 2012|Categories: Chinese Stocks, SEC Original, ZX|Tags: , , , , , |0 Comments

ZX [China Zenix Auto International] 6-K: ZENIX AUTO’S CHAIRMAN EXERCISES OPTION TO PURCHASE SHARES

[ZENIX AUTO’S CHAIRMAN EXERCISES OPTION TO PURCHASE SHARES ZHANGZHOU, China, December 20, 2012 – China Zenix Auto International Limited (NYSE: ZX) Mr. Lai commented, “This transaction further aligns my interest with our other shareholders as we strengthen our strategies to capture market share in this challenging business environment, produce strong free cash-flow and prepare for the introduction of our new]

By | 2016-02-29T20:56:00+00:00 December 20th, 2012|Categories: Chinese Stocks, Webplus ver, ZX|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): December 14, 2012 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last]

By | 2016-03-03T11:31:48+00:00 December 20th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar